HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT

본 발명은 HIV 화합물 아타자나비르 및 코비시스타트의 제제, 및 이들 제제를 이용하는 치료 방법을 기술한다. Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity....

Full description

Saved in:
Bibliographic Details
Main Authors KOO OTILIA MAY YUE, TAO JING, KOTTALA NIRANJAN KUMAR, NIKFAR FARANAK, VARIA SAILESH A
Format Patent
LanguageEnglish
Korean
Published 30.05.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:본 발명은 HIV 화합물 아타자나비르 및 코비시스타트의 제제, 및 이들 제제를 이용하는 치료 방법을 기술한다. Formulations of the HIV compounds atazanavir and cobicistat such as tablet comprising atazanavir and cobicistat comprising having less than about 3% total cobicistat impurities after 8 weeks at 40 ° C and 75% relative humidity.
Bibliography:Application Number: KR20167011723